EKF Diagnostics Holdings PLC Posting of AR & Accounts and Notice of AGM (0159X)
April 25 2019 - 2:00AM
UK Regulatory
TIDMEKF
RNS Number : 0159X
EKF Diagnostics Holdings PLC
25 April 2019
EKF Diagnostics Holdings plc
("EKF", the "Company")
Posting of Annual Report & Accounts and Notice of AGM
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed
point-of-care business, confirms that the Annual Report and
Accounts for the year ended 31 December 2018 ("2018 Annual Report")
and the Notice of the Annual General Meeting contained therein (the
"Notice of AGM") are available on the Company's website:
https://www.ekfdiagnostics.com/hres/Annual-report-2018-Digital.pdf
The 2018 Annual Report, the Notice of AGM and forms of proxy
were posted to shareholders on the 8 April 2019. Shareholders were
also sent an accompanying letter requesting agreement for the
Company to use electronic communication to provide documents and
information to them via the EKF website, together with a copy of
the amended Articles of Association to enable this, subject to the
passing of the relevant resolution to be put to shareholders at the
AGM.
The AGM is to be held on 2 May 2019 at 11am at the offices of
Harwood Capital LLP, 6 Stratton Street, Mayfair, London W1J
8LD.
Enquiries:
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Aubrey Powell / Lauren Kettle / George Tzimas
(Corporate Finance)
Tom Salvesen (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus/ Lianne Cawthorne Mob: 07980 541 893 / 07584
391 303
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is a leading point-of-care diagnostics and central
laboratory assay manufacturer with an estimated 80,000 hemoglobin,
hematocrit, HbA1c, glucose and lactate analyzers in regular use
across more than 100 countries. EKF specializes in developing tests
for use in anemia and diabetes diagnosis and management, as well as
providing a portfolio of reagents for use in clinical chemistry
analyzers.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCCKQDDCBKDDQB
(END) Dow Jones Newswires
April 25, 2019 02:00 ET (06:00 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2024 to May 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From May 2023 to May 2024